Literature DB >> 25855497

Targeting cancer-testis antigens in recurrent pediatric brain tumors.

Deepa K Krishnadas1, Fanqi Bai, Kenneth G Lucas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855497     DOI: 10.1007/s11060-015-1765-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

1.  MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.

Authors:  Lei Bao; Kimberly Dunham; Kenneth Lucas
Journal:  Cancer Immunol Immunother       Date:  2011-05-28       Impact factor: 6.968

2.  Cancer-testis (CT) antigen expression in medulloblastoma.

Authors:  Sueli M Oba-Shinjo; Otavia L Caballero; Achim A Jungbluth; Sergio Rosemberg; Lloyd J Old; Andrew J G Simpson; Suely K N Marie
Journal:  Cancer Immun       Date:  2008-04-22

3.  Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma.

Authors:  Deepa Kolaseri Krishnadas; Teresa Shapiro; Kenneth Lucas
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

4.  Selective cancer-germline gene expression in pediatric brain tumors.

Authors:  Joannes F M Jacobs; Oliver M Grauer; Francis Brasseur; Peter M Hoogerbrugge; Pieter Wesseling; Corrie E Gidding; Mandy W M M van de Rakt; Carl G Figdor; Pierre G Coulie; I Jolanda M de Vries; Gosse J Adema
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

  4 in total
  1 in total

Review 1.  The current landscape of immunotherapy for pediatric brain tumors.

Authors:  Eugene I Hwang; Elias J Sayour; Catherine T Flores; Gerald Grant; Robert Wechsler-Reya; Lan B Hoang-Minh; Mark W Kieran; Joanne Salcido; Robert M Prins; John W Figg; Michael Platten; Kate M Candelario; Paul G Hale; Jason E Blatt; Lance S Governale; Hideho Okada; Duane A Mitchell; Ian F Pollack
Journal:  Nat Cancer       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.